Carregant...
Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled Trials
BACKGROUND: Previous clinical trials of α7-nicotinic acetylcholine receptor agonists (α7-nAChR agonists) showed mixed results in treating the cognitive and negative symptoms of schizophrenia. AIMS: To assess the efficacy and safety of α7-nAChR agonists in treating the cognitive and negative symptoms...
Guardat en:
| Publicat a: | Shanghai Arch Psychiatry |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Shanghai Municipal Bureau of Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5608991/ https://ncbi.nlm.nih.gov/pubmed/28955138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11919/j.issn.1002-0829.217044 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|